Connection
Christina Aquilante to Prognosis
This is a "connection" page, showing publications Christina Aquilante has written about Prognosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.067 |
|
|
|
-
Aquilante CL. Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms. Expert Rev Cardiovasc Ther. 2010 Mar; 8(3):359-72.
Score: 0.050
-
Schoeppler KE, Aquilante CL, Kiser TH, Fish DN, Zamora MR. The impact of genetic polymorphisms, diltiazem, and demographic variables on everolimus trough concentrations in lung transplant recipients. Clin Transplant. 2014 May; 28(5):590-7.
Score: 0.017